Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress

Journal of Molecular Neuroscience

Volumn 43, Issue 3, 2011, Pages 290-302

  Riedel, Michael ^a   Goldbaum, Olaf ^a   Wille, Michael ^a   Richter Landsberg, Christiane ^a  

^a UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

Synuclein; Glial inclusion bodies; Oligodendrocytes; Polyunsaturated fatty acid; SUMO

Indexed keywords

ALPHA CRYSTALLIN; ALPHA SYNUCLEIN; DOCOSAHEXAENOIC ACID; HEME OXYGENASE 1; HYDROGEN PEROXIDE; MEMBRANE LIPID; MUTANT PROTEIN; SERINE; SUMO 1 PROTEIN; UBIQUITIN;

ANIMAL CELL; ARTICLE; CELL AGGREGATION; CELL ASSAY; CELL INCLUSION; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; CELL STRUCTURE; CELLULAR STRESS RESPONSE; CHEMICAL MODIFICATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; NONHUMAN; OLIGODENDROGLIA; OLIGOMERIZATION; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RAT; SOLUBILITY; WESTERN BLOTTING; WILD TYPE;

ALPHA-SYNUCLEIN; ANIMALS; CELL LINE; DOCOSAHEXAENOIC ACIDS; HUMANS; HYDROGEN PEROXIDE; INCLUSION BODIES; MEMBRANE LIPIDS; OLIGODENDROGLIA; OXIDANTS; OXIDATIVE STRESS; RATS; SUMO-1 PROTEIN;

EID: 79955807710     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9439-5     Document Type: Article

References (45)

1. Alessandri JM, Guesnet P, Vancassel S et al (2004) Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev 44:509-538 (Pubitemid 40309154)
2. Bossis G, Melchior F (2006) Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol Cell 21:349-357 (Pubitemid 43163530)
3. Brand A, Yavin E (2001) Early ethanolamine phospholipid translocation marks stress-induced apoptotic cell death in oligodendroglial cells. J Neurochem 78:1208-1218 (Pubitemid 32899753)
4. Brand A, Gil S, Yavin E (2000) N-Methyl bases of ethanolamine prevent apoptotic cell death induced by oxidative stress in cells of oligodendroglia origin. J Neurochem 74:1596-1604 (Pubitemid 30163981)
5. Brand A, Gil S, Seger R, Yavin E (2001) Lipid constituents in oligodendroglial cells alter susceptibility to H2O2-induced apoptotic cell death via ERK activation. J Neurochem 76:910-918 (Pubitemid 32126091)
6. Brand A, Bauer NG, Hallot A, Goldbaum O, Ghebremeskel K, Reifen R, Richter-Landsberg C (2010) Membrane lipid modification by polyunsaturated fatty acids sensitizes oligodendroglial OLN-93 cells against oxidative stress and promotes upregulation of heme oxygenase-1 (HSP32). J Neurochem 113:465-476
7. Burn DJ, Jaros E (2001) Multiple system atrophy: cellular and molecular pathology. Mol Pathol 54:419-426 (Pubitemid 34025258)
8. Castagnet PI, Golovko MY, Barcelo-Coblijn GC, Nussbaum RL, Murphy EJ (2005) Fatty acid incorporation is decreased in astrocytes cultured from alpha-synuclein gene-ablated mice. J Neurochem 94:839-849 (Pubitemid 41098515)
9. Chen L, Feany MB (2005) Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson's disease. Nat Neurosci 8:657-663 (Pubitemid 40594208)
10. Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443-9449 (Pubitemid 28183026)
11. De Franceschi G, Frare E, Bubacco L, Mammi S, Fontana A, de Laureto PP (2009) Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid. J Mol Biol 394:94-107
12. Dennery PA (2000) Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul 36:181-199
13. Dorval V, Fraser PE (2006) Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J Biol Chem 281:9919-9924 (Pubitemid 43864524)
14. Dorval V, Fraser PE (2007) SUMO on the road to neurodegeneration. Biochim Biophys Acta 1773:694-706 (Pubitemid 46830946)
15. Dyall SC, Michael-Titus AT (2008) Neurological benefits of omega-3 fatty acids. Neuromolecular Med 10:219-235
16. Forman MS, Trojanowski JQ, Lee VM (2004) Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10:1055-1063 (Pubitemid 39424865)
17. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160-164
18. Geiss-Friedlander R, Melchior F (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8:947-956 (Pubitemid 350176509)
19. Giannakis E, Pacifico J, Smith DP, Hung LW, Masters CL, Cappai R, Wade JD, Barnham KJ (2008) Dimeric structures of alpha-synuclein bind preferentially to lipid membranes. Biochim Biophys Acta 1778:1112-1119
20. Goldbaum O, Oppermann M, Handschuh M, Dabir D, Zhang B, Forman MS, Trojanowski JQ, Lee VM, Richter-Landsberg C (2003) Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid. J Neurosci 23:8872-8880 (Pubitemid 37210900)
21. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634-1658
22. Jellinger KA (2009) Recent advances in our understanding of neurodegeneration. J Neural Transm 116:1111-1162
23. Kahle PJ, Neumann M, Ozmen L et al (2002) Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 3:583-588 (Pubitemid 34752460)
24. Kragh CL, Lund LB, Febbraro F, Hansen HD, Gai WP, El-Agnaf O, Richter-Landsberg C, Jensen PH (2009) {alpha}-Synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells. J Biol Chem 284:10211-10222
25. Lansbury PT, Lashuel HA (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443:774-779 (Pubitemid 44622681)
26. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury PT Jr (2002) alpha-Synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322:1089-1102 (Pubitemid 35266514)
27. Lee HJ, Lee SJ (2002) Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J Biol Chem 277:48976-48983
28. Lee VM, Giasson BI, Trojanowski JQ (2004) More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases. Trends Neurosci 27:129-134 (Pubitemid 38251512)
29. Martin S, Wilkinson KA, Nishimune A, Henley JM (2007) Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci 8:948-959 (Pubitemid 350146936)
30. Neuhoff V, Philipp K, Zimmer HG, Mesecke S (1979) A simple, versatile, sensitive and volume-independent method for quantitative protein determination which is independent of other external influences. Hoppe Seylers Z Physiol Chem 360:1657-1670 (Pubitemid 10160925)
31. Norris EH, Giasson BI, Ischiropoulos H, Lee VM (2003) Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications. J Biol Chem 278:27230-27240 (Pubitemid 36876880)
32. Perrin RJ, Woods WS, Clayton DF, George JM (2001) Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J Biol Chem 276:41958-41962
33. Pountney DL, Chegini F, Shen X, Blumbergs PC, Gai WP (2005) SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Neurosci Lett 381:74-79 (Pubitemid 40693145)
34. Richter-Landsberg C, Heinrich M (1996) OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res 45:161-173 (Pubitemid 26257317)
35. Richter-Landsberg C, Bauer NG (2004) Tau-inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition. Int J Dev Neurosci 22:443-451 (Pubitemid 39311433)
36. Riedel M, Goldbaum O, Richter-Landsberg C (2009) alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: effects of oxidative and proteolytic stress. J Mol Neurosci 39:226-234
37. Ross CA, Poirier MA (2005) Opinion: what is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol 6:891-898
38. Sharon R, Goldberg MS, Bar-Josef I, Betensky RA, Shen J, Selkoe DJ (2001) alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci USA 98:9110-9115 (Pubitemid 32743877)
39. Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ (2003) The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 37:583-595 (Pubitemid 36262981)
40. Stahnke T, Stadelmann C, Netzler A, Bruck W, Richter-Landsberg C (2007) Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders. J Mol Neurosci 32:25-37 (Pubitemid 47450554)
41. Stöckl M, Fischer P, Wanker E, Herrmann A (2008) alpha-Synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. J Mol Biol 375:1394-1404
42. Um JW, Chung KC (2006) Functional modulation of parkin through physical interaction with SUMO-1. J Neurosci Res 84:1543-1554 (Pubitemid 44683147)
43. Wenning GK, Jellinger KA (2005) The role of alpha-synuclein and tau in neurodegenerative movement disorders. Curr Opin Neurol 18:357-362 (Pubitemid 41104796)
44. Yavin E (2006) Docosahexaenoic acid: a pluripotent molecule acting as a membrane fluidizer, a cellular antioxidant and a modulator of gene expression. Nutr Health 18:261-262
45. Yavin E, Brand A, Green P (2002) Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr Neurosci 5:149-157 (Pubitemid 34568212)